Characterizing the course of suicidal ideation response to ketamine

Background: : No pharmacological treatments exist for active suicidal ideation (SI), but the glutamatergic modulator ketamine elicits rapid changes in SI. We developed data-driven subgroups of SI trajectories after ketamine administration, then evaluated clinical, demographic, and neurobiological fa...

Full description

Bibliographic Details
Main Authors: Ballard, E.D (Author), Farmer, C.A (Author), Kadriu, B. (Author), Machado-Vieira, R. (Author), Niciu, M.J (Author), Park, L. (Author), Richards, E. (Author), Yarrington, J.S (Author), Yuan, P. (Author), Zarate, C.A., Jr (Author)
Format: Article
Language:English
Published: Elsevier B.V. 2018
Subjects:
Online Access:View Fulltext in Publisher